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Background:  Vaccinia virus gene B1R encodes a serine/threonine protein kinase. In vitro this pro-
tein kinase phosphorylates ribosomal proteins Sa and S2 and vaccinia virus protein H5R, proteins
that become phosphorylated during infection. Nothing is known about the sites phosphorylated on
these proteins or the general substrate specificity of the kinase. The work described is the first to
address these questions.
Results:  Vaccinia virus protein H5R was phosphorylated by the B1R protein kinase in vitro, digest-
ed with V8 protease, and phosphopeptides separated by HPLC. The N-terminal sequence of one
radioactively labelled phosphopeptide was determined and found to correspond to residues 81-87
of the protein, with Thr-84 and Thr-85 being phosphorylated. A synthetic peptide based on this
region of the protein was shown to be a substrate for the B1R protein kinase, and the extent of
phosphorylation was substantially decreased if either Thr residue was replaced by an Ala.
Conclusions:  We have identified the first phosphorylation site for the vaccinia virus B1R protein
kinase. This gives important information about the substrate-specificity of the enzyme, which differs
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Figure 1
HPLC fractionation of V8 peptides from vaccinia virus protein 
H5R. (a) HPLC fractionation of hydrolysate after passage 
through a SEP-PAK column using a gradient of 0-50% ace-
tonitrile. The fractions encompassed by the horizontal bar 
(region 3) were collected for further analysis. (b) Microbore 
HPLC fractionation of region 3 from (a). A gradient of 15-25% 
acetonitrile in 0.1% trifluoroacetic acid was used and the frac-
tions encompassed by the horizontal bars (regions I and II) 
collected for further analysis). (c) Microbore HPLC fractiona-
tion of region II from (b). A gradient of 0-50% acetonitrile in 
20 mM NaCl (in the absence of trifluoroacetic acid - i.e. at 
neutral pH) was used and the fractions 28 and 29 collected for 
sequence analysis). The direction of increasing gradient is 
from left to right in all three frames; the ultraviolet absorb-
ance trace is labelled as A280, and the radioactivity trace as 
32P.
Figure 2
Sequence analysis of H5R phosphopeptide. Fraction 29 from 
Fig 1 was subjected to automatic Edman degradation, and the 
32P radioactivity released at each stage measured. The identity 
of the phenylthiohydantoin derivative from the first seven cy-
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Figure 3
Phosphorylation of synthetic peptides. Peptides were phos-
phorylated as described in the Experimental section and sub-
jected to electrophoresis on thin-layer cellulose at pH 3.5. 
The position of the phosphopeptides is indicated by the ar-
row, the identification being based on the fact that the ninhy-
drin-stained material (predominantly unphosphorylated and 
hence with a greater positive charge) migrated just ahead of 
this. Lane 1 contained RRIEEYHQTTEKN, lane 2: RRIEEY-
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